Progesterone reduces depressive behavior of young ovariectomized, aged progestin receptor knockout, and aged wild type mice in the tail suspension test

Journal of Psychopharmacology

Volumn 25, Issue 3, 2011, Pages 421-428

  Frye, Cheryl A ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

aging; allopregnanolone; depression; neurosteroids; non genomic; senescent

Indexed keywords

PROGESTERONE; PROGESTERONE RECEPTOR;

AGED; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; EXPERIMENTAL TEST; FEMALE; GENOTYPE; GONADECTOMY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SENESCENCE; TAIL; THERAPY EFFECT; WILD TYPE;

AGE FACTORS; ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORCHIECTOMY; OVARIECTOMY; PROGESTERONE; RECEPTORS, PROGESTERONE;

EID: 79952121271     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109349836     Document Type: Article

References (99)

1. Angst J., Sellaro R., Merikangas KR, Endicott J. (2001) The epidemiology of premenstrual psychological symptoms. Acta Psychiatr Scand 104: 110-116.
2. Backstrom T., Andreen L., Birzniece V., et al. (2003) The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs 17: 325-342. (Pubitemid 36469971)
3. Ballinger CB, Browning MC, Smith AH (1987) Hormone profiles and psychological symptoms in peri-menopausal women. Maturitas 9: 235-251. (Pubitemid 17163571)
4. Barros HM, Ferigolo M. (1998) Ethopharmacology of imipramine in the forced-swimming test: gender differences. Neurosci Biobehav Rev 23: 279-286. (Pubitemid 29011630)
5. Becker J., Cha J. (1989) Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav Brain Res 35: 117-125. (Pubitemid 19268404)
6. Bekku N., Yoshimura H. (2005) Animal model of menopausal depressive-like state in female mice: prolongation of immobility time in the forced swimming test following ovariectomy. Psychopharmacology (Berl) 183: 300-307. (Pubitemid 41660415)
7. Bekku N., Yoshimura H., Araki H. (2006) Factors producing a menopausal depressive-like state in mice following ovariectomy. Psychophamarmacology (Berl) 187: 170-180. (Pubitemid 44015611)
8. Bernardi M., Vergoni A., Sandrini M., Tagliavini S., Bertolini A. (1989) Influence of ovariectomy, estradiol and progesterone on the behavior of mice in an experimental model of depression. Physiol Behav 45: 1067-1068. (Pubitemid 19158301)
9. Bethea C., Lu N., Gundlah C., Streicher J. (2002) Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23: 41-100. (Pubitemid 34121908)
10. Bilkei-Gorzo A., Racz I., Michel K., Zimmer AJ (2002) Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene. Neurosci 22: 10046-10052. (Pubitemid 35332890)
11. Bitran D., Hilvers R., Kellogg C. (1991) Ovarian endocrine status modulates the anxiolytic potency of diazepam and the efficacy of gamma-aminobutyric acid-benzodiazepine receptor-mediated chloride ion transport. Behav Neurosci 105: 653-662.
12. Blasey CM, Debattista C., Roe R., Block T., Belanoff JK (2009) A multi-site trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction. Contemp Clin Trials 30: 284-288.
13. Claudia P., Andrea C., Chiara C., et al. (2004) Panic disorder in menopause: a case control study. Maturitas 48: 147-154. (Pubitemid 38692577)
14. Compagnone NA, Mellon SH (2000) Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol 21: 1-56. (Pubitemid 30105920)
15. DeBattista C., Belanoff J. (2006) Mifepristone, versus placebo in the treatment of psychosis in patients with psychotic major depression. Biol Psychiatry 12: 1343-1349. (Pubitemid 44838535)
16. Dong E., Matsumoto K., Uzunova V., et al. (2001) Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc Natl Acad Sci U S A 98: 2849-2854. (Pubitemid 32209572)
17. Drossopoulou G., Antoniou K., Kitraki E., et al. (2004) Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats. Neuroscience 126: 849-857. (Pubitemid 38780890)
18. Endicott J., Amsterdam J., Eriksson E., et al. (1999) Is premenstrual dysphoric disorder a distinct clinical entity ? J Womens Health Gend Based Med 8: 663-679. (Pubitemid 29414632)
19. Espallergues J., Givalois L., Temsamani J., Laruelle C., Maurice T (2009) The 3B-hydroxysteriod dehydrogenase inhibitor trilostane shows antidepressant properties in mice. Psychoneuroendocrinology 34: 644-659.
20. Fadalti M., Petraglia F., Luisi S., et al. (1999) Changes of serum allopregnanolone levels in the first two years of life and during pubertal development. Pediatr Res 46: 323-327. (Pubitemid 29400578)
21. Fitzpatrick LA, Pace C., Wiita B. (2000) Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: a cross-sectional survey. J Womens Health Gend Based Med 9: 381-387. (Pubitemid 30411749)
22. Freeman EW, Frye CA, Rickels K., Martin PA, Smith SS (2002) Allopregnanolone levels and symptom improvement in severe premenstrual syndrome. J Clin Psychopharmacol 22: 516-520.
23. Freeman EW, Frye CA, and Sheng, Li (2009) Allopregnanolone levels before and after SSRI treatment for premenstrual symptoms. J Clin Psychopharmacol (in press).
24. Frick KM, Burlingame LA, Arters JA, Berger-Sweeney J. (2000) Reference memory, anxiety and estrous cyclicity in C57BL/ 6NIA mice are affected by age and sex. Neuroscience 95: 293-307.
25. Frye CA, Petralia S., Rhodes ME (2000) Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3α,5α-THP. Pharmacol Biochem Behav 67: 587-596. (Pubitemid 32103570)
26. Frye CA, Seliga AM (2003) Olanzapine's effects to reduce fear and anxiety and enhance social interactions coincide with increased progestin concentrations of ovariectomized rats. Psychoneuroendocrinology 28: 657-673. (Pubitemid 36519658)
27. Frye CA, Sumida K., Dudek B., et al. (2006 a) Progesterone's effects to reduce anxiety behavior of aged mice do not require actions via intracellular progestin receptors. Psychopharmacology (Berl) 186: 312-322. (Pubitemid 43800833)
28. Frye CA, Sumida K., Harney JP, Lydon J., O'Malley BW, Pfaff D. (2006 b) Mid-aged and aged wildtype and PRKO mice demonstrate rapid progesterone and 3α,5α-THP-facilitated lordosis. Psychopharmacology (Berl) 185: 423-432.
29. Frye CA, Walf AA (2002) Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav 41: 306-315. (Pubitemid 34499458)
30. Frye CA, Walf AA (2004) Hippocampal 3α,5α-THP may alter depressive behavior of pregnant and lactating rats. Pharmacol Biochem Behav 78: 531-540. (Pubitemid 38901020)
31. Frye CA, Walf AA (2008) Progesterone to ovariectomized mice enhances cognitive performance in the spontaneous alteration, object recognition, but not placement, water maze and contextual and cued conditioned fear tasks. Neurobiol Learn Mem 90: 171-177.
32. Frye CA, Walf AA (2009) Depression-like behavior of aged male and female mice is ameliorated with administration of testosterone or its metabolites. Physiol Behav 97: 266-269.
33. Frye CA, Walf AA, Rhodes ME, Harney JP (2004) Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5alpha-reductase. Brain Res 9: 116-124. (Pubitemid 38368067)
34. Frye CA, Wawrzycki J. (2003) Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats. Horm Behav 44: 319-326. (Pubitemid 37378211)
35. Galea L., Wide J., Barr A. (2001) Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression. Behav Brain Res 122: 1-9. (Pubitemid 32241787)
36. Gallagher P., Watson S., Elizabeth Dye C., Young AH, Nicol Ferrier I. (2008) Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia. J Psychiatr Res 42: 1037-1041.
37. Girdler SS, Straneva PA, Light KC, Pedersen CA, Morrow AL (2001) Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 49: 788-797. (Pubitemid 32452300)
38. Glick ID, Bennett SE (1981) Psychiatric complications of progesterone and oral contraceptives. J Clin Psychopharmacol 1: 350-367. (Pubitemid 12189859)
39. Griffin L., Mellon S. (1999) Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci U S A 96: 13512-13517.
40. Guidotti A., Dong E., Matsumoto K., Pinna G., Rasmusson AM, Costa E. (2001) The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5alpha-dihydroprogesterone in psychiatric disorders. Brain Res Brain Res Rev 37: 110-115. (Pubitemid 34020725)
41. Gulinello M., Gong QH, Smith SS (2003) Progesterone withdrawal increases the anxiolytic actions of gaboxadol: role of alpha4beta-delta GABAA receptors. Neuroreport 14: 43-46. (Pubitemid 36160739)
42. Hardoy MC, Sardu C., Dell'osso L., Carta MG (2008) The link between neurosteroids and syndromic/syndromal components of the mood spectrum disorders in women during the premenstrual phase. Clin Pract Epidemol Ment Health 4: 3.
43. Hardoy MC, Serra M., Carta MG, Contu P., Pisu MG, Biggio G. (2006) Increased neuroactive steroid concentrations in women with bipolar disorder and major depressive disorder. J Clin Psychopharmacol 26: 379-384. (Pubitemid 44187639)
44. Hirani K., Khisti R., Chopde C. (2002) Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3alpha-hydroxy-5 alpha-pregnan-20-one. Neuropharmacology 43: 1339-1350. (Pubitemid 36084444)
45. Joffe H., Soares CN, Cohen LS (2003) Assessment and treatment of hot flushes and menopausal mood disturbance. Psychiatr Clin North Am 26: 563-580. (Pubitemid 37175496)
46. Kaur G., Kulkarni S. (2002) Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice. Brain Res 943: 206-215. (Pubitemid 36124005)
47. Khisti RT, Chopde CT (2000) Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alphapregnan-20- one in mice. Brain Res 865: 291-300. (Pubitemid 30256011)
48. Khisti RT, Chopde CT, Jain SP (2000) Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav 67: 137-143.
49. Klier CM, Muzik M., Dervic K., et al. (2007) The role of estrogen and progesterone in depression after birth. J Psychiatr Res 41: 273-279. (Pubitemid 44855000)
50. Kulkarni SK, Dhir A. (2008) On the mechanism of antidepressant-like action of berbine chloride. Eur J Pharmacol 589: 163-172.
51. Lambert JJ, Belelli D., Hill-Venning C., Peters JA (1995) Neurosteroids and GABAA receptor function. Trends Pharmacol Sci 16: 295-303.
52. Lan N., Gee K. (1994) Neuroactive steroid actions at the GABAA receptor. Horm Behav 28: 537-544.
53. Lancel M., FaulhaberJ, Holsboer F., Rupprecht R. (1996) Progesterone induces changes in sleep comparable to those of agonistic GABAA receptor modulators. Am J Physiol 271: 763-772.
54. Lancel M., Faulhaber J., Holsboer F., Rupprecht R. (1999) The GABA(A) receptor antagonist picrotoxin attenuates most sleep changes induced by progesterone. Psychopharmacology (Berl) 141: 213-219. (Pubitemid 29200174)
55. Lebowitz BD, Pearson JL, Schneider LS, et al. (2006) Diagnosis and treatment of depression in late life: consensus statement update. J Am Med Assoc 278: 1186-1190.
56. Longcope C. (1990) Hormone dynamics at the menopause. Ann N Y Acad Sci 592: 21-30. (Pubitemid 20273204)
57. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232: 1004-1007. (Pubitemid 16085410)
58. Mani SK, Blaustein JD, O'Malley BW (1997) Progesterone receptor function from a behavioral perspective. Horm Behav 31: 244-255. (Pubitemid 27305722)
59. Markou A., Duka T., Prelevic GM (2005) Estrogens and brain function. Hormones 4: 9-17.
60. Marvan ML, Santana S., Chavez Chavez L., Bertran M. (1997) Inescapable shocks accentuate fluctuations of forced swimming immobility in different phases of the rat estrous cycle. Arch Med Res 28: 369-372. (Pubitemid 27401643)
61. Marx CE, VanDoren MJ, Duncan GE, Lieberman JA, Morrow AL (2003) Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. Neuropsychopharmacology 28: 1-13.
62. Molina-Hernández M., Contreras C., Tellez-Alcantara P. (2000) Antidepressant-like effects of pregnancy and progesterone in Wistar rats as measured in the differential reinforcement of the low-rate 72 s task. Psychopharmacology (Berl) 151: 306-311.
63. Molina-Hernandez M., Tellez-Alcantara NP, Garcia JP, Lopez JI, Jaramillo MT (2005) Antidepressant-like actions of intra-accumbens infusions of allopregnanolone in ovariectomized Wistar rats. Pharmacol Biochem Behav 80: 401-409. (Pubitemid 40299341)
64. Murphy BE (1997) Antiglucocorticoid therapies in major depression: a review. Psychoneuroendocrinology 1, Supplement 1: S25 - S32.
65. Nelson J., Felicio L., Osterburg H., Finch C. (1992) Differential contributions of ovarian and extraovarian factors to age-related reductions in plasma estradiol and progesterone during the estrous cycle of C57BL/6J mice. Endocrinology 130: 805-810.
66. Nicol M., Hirst J., Walker D. (1999) Effects of pregnanolone on behavioural parameters and the responses to GABA(A) receptor antagonists in the late gestation fetal sheep. Neuropharmacology 38: 49-63. (Pubitemid 29073526)
67. Nihalani ND, Schwartz TL (2007) Mifepristone, a glucocorticoid antagonist for the potential treatment of psychotic major depression. Curr Opin Investig Drugs 8: 563-569. (Pubitemid 47016324)
68. Paoletti AM, Romagnino S., Contu R., et al. (2006) Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABAA receptor agonist activity. Psychoneuroendocrinology 31: 485-492. (Pubitemid 43375950)
69. Paré WP, Redei E. (1993) Sex differences and stress response of WKY rats. Physiol Behav 54: 1179-1185. (Pubitemid 23343142)
70. Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6: 2311-2322.
71. Pearlstein TB (1995) Hormones and depression: what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy? Am J Obstet Gynecol 173: 646-653.
72. Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA (2005) Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 72: 414-421. (Pubitemid 41676830)
73. Pearlstein TB, Rosen K., Stone AB (1997) Mood disorders and menopause. Endocrinol Metab Clin North Am 26: 279-294. (Pubitemid 27265441)
74. Perrot-Sinal TS, Kavaliers M., Ossenkopp K. (1998) Spatial learning and hippocampal volume in male deer mice: relations to age, testosterone and adrenal gland weight. Neuroscience 86: 1089-1099. (Pubitemid 28318535)
75. Porsolt RD, Le Pichon M., Jalfre M. (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266: 730-732. (Pubitemid 8073804)
76. Rapkin AJ, Morgan M., Goldman L., Brann DW, Simone D., Mahesh VB (1997) Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90: 709-714. (Pubitemid 27449718)
77. Rapkin AJ, Mikacich JA, Moatakef-Imani B., Rasgon N. (2002) The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders. Curr Psychiatry Rep 4: 419-428.
78. Rodríguez-Landa JF, Contreras CM, Bernal-Morales B., GutiérrezGarcía AG, Saavedra M. (2007) Allopregnanolone reduces immobility in the forced swimming test and increases the firing rate of lateral septal neurons through actions on the GABAA receptor in the rat. J Psychopharmacol 21: 76-84. (Pubitemid 46012086)
79. Romeo E., Ströhle A., Spalletta G., et al. (1998) Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155: 910-913. (Pubitemid 28307602)
80. Schmidt PJ, Purdy RH, Moore PH, Jr, Paul SM, Rubinow DR (1994) Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 79: 1256-1260. (Pubitemid 24369832)
81. Schule C., Baghai TC, Di Michele F., et al. (2007) Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients. Psychoneuroendocrinology 32: 669-680. (Pubitemid 47017587)
82. Sherwin BB (1991) The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 72: 336-343. (Pubitemid 21921696)
83. Sherwin BB, Gelfand MM (1989) A prospective one-year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids. Obstet Gynecol 73: 759-766. (Pubitemid 19116895)
84. Soares CN, Zitek B. (2008) Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability ? J Psychiatry Neurosci 33: 331-343. (Pubitemid 351977159)
85. Stahl SM (1997) Are two antidepressant mechanisms better than one ? J Clin Psychiatry 58: 339-340. (Pubitemid 27375460)
86. Steru L., Chermat R., Thierry B., Simon P. (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85: 367-370. (Pubitemid 15123115)
87. Stoffel E., Craft R. (2004) Ovarian hormone withdrawal-induced ''depression'' in female rats. Physiol Behav 83: 505-513. (Pubitemid 39591635)
88. Sun MK, Alkon DL (2006) Differential gender-related vulnerability to depression induction and converging antidepressant responses in rats. J Pharmacol Exp Ther 316: 926-932. (Pubitemid 43136539)
89. Svare B. (1988) Genotype modulates the aggression-promoting quality of progesterone in pregnant mice. Horm Behav 22: 90-99. (Pubitemid 18082193)
90. Uzunova V., Sampson L., Uzunov DP (2006) Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action. Psychopharmacology (Berl) 186: 351-361. (Pubitemid 43800837)
91. Uzunova V., Sheline Y., Davis JM, et al. (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 95: 3239-3244. (Pubitemid 28135886)
92. Uzunova V., Wrynn A., Kinnunen A., Ceci M., Kohler C., Uzunov D. (2004) Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat. Eur J Pharmacol 486: 31-34. (Pubitemid 38130158)
93. Van Look PF, Von Hertzen H. (1995) Clinical use of antiprogestins. Hum Reprod 1: 19-34.
94. Walf AA, Frye CA (2007) Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol Biochem Behav 86: 407-414. (Pubitemid 46282041)
95. Walf AA, Koonce CJ, Frye CA (2008 a) Estradiol or diarylpropionitrile decrease anxiety-like behavior of wildtype, but not estrogen receptor beta knockout mice. Behav Neurosci 122: 974-981.
96. Walf AA, Koonce CJ, Frye CA (2008 b) Estradiol or diarylpropionitrile administration to wild type, but not estrogen receptor beta knockout mice enhances performance in the object recognition and object placement tasks. Neurobiol Learn Mem 89: 513-521.
97. Walf AA, Sumida K., Frye CA (2006 b) Inhibiting 5alpha-reductase in the amygdala attenuates antianxiety and antidepressive behavior of naturally receptive and hormone-primed ovariectomized rats. Psychopharmacology (Berl) 186: 302-311. (Pubitemid 43800832)
98. Wu LM, Han H., Wang QN, et al. (2007) Mifepristone repairs region-dependent alteration of synapsin I in hippocampus in rat model of depression. Neuropsychopharmacology 32: 2500-2510. (Pubitemid 350126839)
99. Zhang HT, Huang Y., Masood A., et al. (2008) Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychopharmacology 33: 1611-1623. (Pubitemid 351684706)